SARS-CoV-2 Nucleocapsid Proteins

The SARS-CoV-2 Nucleocapsid (N) protein remains one of the most abundant and frequently detected viral structural proteins and continues to attract attention as a potential therapeutic and research target beyond the viral entry stage. The role of the N protein in complement activation and inflammatory pathology is not yet fully understood. Furthermore, because the N protein is central to viral genome packaging and assembly and is highly immunogenic, high-quality recombinant N protein continues to be indispensable for a wide range of applications — from serological assays and immunogen design to structural and functional studies, and the development of novel therapeutic interventions. Below you can browse our current selection of recombinant SARS-CoV-2 Nucleocapsid proteins, produced and quality-controlled for research and vaccine development. Discover our high-quality recombinant SARS-CoV-2 Nucleocapsid Proteins down below!